curacle큐라클
365270 · KOSDAQ · ₩365270 · 큐라클
₩8,020▼ ₩190 (2.31%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩7.2B | ₩1B | ₩0 | — | — | — | ₩1.1B | ₩0 |
| Operating income | ₩2.4B | −₩3B | −₩4.7B | −₩2.9B | −₩5.3B | −₩3.6B | −₩2.4B | −₩3.3B |
| Net income | ₩3.2B | −₩3.1B | −₩4.7B | −₩3B | −₩6.3B | −₩4.1B | −₩4.1B | −₩4.2B |
| Net income to shareholders | ₩3.2B | −₩3.1B | −₩4.7B | −₩3B | −₩6.3B | −₩4.1B | −₩4.1B | −₩4.2B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩59B | ₩55B | ₩53B | ₩56B | ₩38B | ₩56B | ₩59B | ₩60B |
| Current assets | ₩24B | ₩21B | ₩25B | ₩30B | ₩12B | ₩29B | ₩32B | ₩34B |
| Cash and equivalents | ₩9.9B | ₩5.1B | ₩4B | ₩8.2B | ₩10B | ₩2.2B | ₩4B | ₩7.4B |
| Total liabilities | ₩13B | ₩14B | ₩16B | ₩17B | ₩18B | ₩29B | ₩29B | ₩28B |
| Current liabilities | ₩12B | ₩10B | ₩13B | ₩13B | ₩14B | ₩29B | ₩21B | ₩28B |
| Borrowings | ₩11B | ₩8.8B | ₩10B | ₩10B | ₩10B | ₩20B | ₩12B | ₩20B |
| Total equity | ₩47B | ₩42B | ₩37B | ₩39B | ₩21B | ₩27B | ₩30B | ₩32B |
| Shareholders' equity | ₩47B | ₩42B | ₩37B | ₩39B | ₩21B | ₩27B | ₩30B | ₩32B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩2.3B | −₩4.1B | −₩4.1B | −₩3.6B | −₩2.7B | −₩3.1B | −₩3.1B | −₩3.2B |
| Capital spending | −₩26M | −₩1.4M | ₩0 | −₩3.3M | ₩0 | −₩1.1M | −₩77M | −₩135M |
| Free cash flow | ₩2.3B | −₩4.2B | −₩4.1B | −₩3.6B | −₩2.7B | −₩3.1B | −₩3.2B | −₩3.3B |
Consolidated where available. Amounts in won.
Also known as: curacle / 큐라클 / 365270 / KRX:365270
Source: KRX statistical information